Magnets may reduce incisions in stomach surgery
NCT ID NCT07293611
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tests a new magnetic surgical system that could allow surgeons to perform upper stomach surgeries with fewer cuts. The device uses a magnetic grasper inside the body and a controller outside to move tissue. Researchers will check if it's safe and if it can replace some of the usual tools, potentially leading to less pain and faster recovery. The study involves 30 people scheduled for laparoscopic surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Levita Magnetic Surgical System (a device with a magnetic grasper and external controller)
- What this could lead to
- If successful, this could lead to less invasive upper GI surgeries with fewer incisions, potentially reducing pain and recovery time.
- What could go wrong
- This is a small, early feasibility study with only 30 participants. The device may not work as well as standard tools, and there are risks like device malfunction or injury from magnetic forces.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
Jun 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI range of 20 to 60kg/m2 * Scheduled to undergo laparoscopic procedures * Willing and able to provide a written Informed Consent Form (ICF) to participate in the study prior to any study- required procedures Exclusion Criteria: * Individuals with pacemakers, defibrillators, or other electromedical implants * Individuals with ferromagnetic implants * American Society of Anesthesiologists (ASA) score of III or IV * Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure) * Clinical history of impaired coagulation confirmed by abnormal blood tests * Individuals who have signs of hepatic abnormality (e.g.: cirrhosis, liver failure, increase in liver enzymes, etc.) * Anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use * Pregnant or wishes to become pregnant during the length of study participation * Individual is not likely to comply with the follow-up evaluation schedule * Participating in a clinical trial of another investigational drug or device * Prisoner or under incarceration
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Upper gastrointestinal laparoscopic surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Colonial
Huechuraba, Santiago Metropolitan, 8580645, Chile
-
Hospital Luis Tisne
Peñalolén, Santiago Metropolitan, 7930124, Chile